Furthermore, high expression of FKBP6, WRNIP1, POU2F3, REST, TM4SF20, EEF2K, and CDH1 enhanced GBM patients’ survival and significantly decreased the hazard ratio. This evidence concerns the gene TM4SF20 and glioblastoma.